PHAT FY 2019 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$831M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$8,000

Operating Income

-$106M

Net Income

-$210M

EPS (Diluted)

$-8.48

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$62M

Stock-Based Comp.

$406,000

Balance Sheet

Total Assets

$257M

Total Liabilities

$29M

Stockholders' Equity

$228M

Cash & Equivalents

$244M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$8,000	$0	—
Operating Income	-$106M	-$1M	-8570.6%
Net Income	-$210M	-$1M	-16184.5%